引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 128次   下载 62 本文二维码信息
码上扫一扫!
促性腺激素释放激素类似物治疗中枢性性早熟及快进展型青春期儿 童不良反应分析
孙皖玉1,刘德云2
0
((1. 安徽医科大学第二临床医学院,合肥 230000;2. 安徽医科大学第二附属医院,合肥 230000))
摘要:
目的:分析促性腺激素释放激素类似物(GnRHa)治疗中枢性性早熟(CPP)及快进展型青春期(EFP)患儿过程中出现的 明显局部不良反应的临床经验,评估严重不良反应的发生率。方法:回顾性分析2020-2023 年安徽医科大学第二附属医院确诊 为CPP 及EFP 并接受GnRHa 治疗的患儿随访资料,对发生显著不良反应的儿童的临床特征进行分析,并评估不良反应发生 率。结果:接受GnRHa 治疗的635 例患儿中,发生无菌脓肿10 例。33 例患儿注射GnRHa 后出现一过性月经来潮,45 例有注射 部位疼痛、肿胀,41 例曾出现注射部位硬结,1 例出现过敏反应。结论:临床医师应警惕GnRHa 治疗过程中可能出现的不良反 应,并在治疗过程中严密监测。
关键词:  中枢性性早熟  促性腺激素释放激素类似物  快进展型青春期  不良反应  无菌脓肿
DOI:doi:10.13407/j.cnki.jpp.1672-108X.2025.07.012
基金项目:安徽医科大学第二附属医院2024 高校科研计划编制(自科)项目,编号2024AH040105。
Adverse Drug Reactions of Gonadotropin-Releasing Hormone Analogues in the Treatment of CentralPrecocious Puberty and Early and Fast Puberty
Sun Wanyu1, Liu Deyun2
((1. The Second Clinical School of Medicine, Anhui Medical University, Hefei 230000, China; 2. The Second Affiliated Hospital of Anhui Medical University, Hefei 230000, China))
Abstract:
Objective: To analyze the clinical experience of local adverse drug reactions of gonadotropin-releasing hormone analogues (GnRHa) in the treatment of children with central precocious puberty (CPP) and early and fast puberty (EFP), and evaluate the incidence of severe adverse drug reactions. Methods: Retrospective analysis was conducted on the follow-up data of children diagnosed with CPP and EFP and treated with GnRHa at the Second Affiliated Hospital of Anhui Medical University from 2020 to 2023. Clinical characteristics of children with significant adverse drug reactions were analyzed, and the incidence of adverse drug reactions was evaluated. Results: Among the cohort of 635 children undergoing GnRHa treatment, 10 cases had sterile abscesses. Thirty-three children had transient menstruation after GnRHa injection, 45 cases had pain and swelling at the injection site, 41 cases had induration at the injection site, and 1 case had allergic reaction. Conclusion: Clinicians should be alert to possible adverse drug reactions during GnRHa therapy and closely monitor the course of treatment.
Key words:  central precocious puberty  gonadotropin-releasing hormone analogue  early and fast puberty  adverse drug reaction  sterile abscess

用微信扫一扫

用微信扫一扫